162 computer-security "https:" "https:" "https:" "https:" "U.S" positions at King's College London
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of understanding and treating mental ill health ( http://www.kcl.ac.uk/ioppn/ ). The research role is based in the Psychology Department, one of the world’s largest academic groupings of clinical and health
-
are looking to appoint a Programme Manager to join Dr Heathcote’s team within the Health Psychology Group, Department of Psychology at King’s College London. We are seeking a proactive and organized Programme
-
(23:59 GMT), 26th March 2026. On the ‘Choosing a programme’ page, please select Basic and Clinical Neuroscience Research PhD Full-time More information on the department and the programme is available
-
for bacterial or fungal new targets or developing theragnostic agents Radiation safety, regulation and handling radioisotopes Radiochemistry (radiolabelling of compounds, purity, stability and in vitro
-
members and 110 PhD students, and offers an exceptional multidisciplinary environment for cutting-edge cardiovascular and metabolic research. Learn more about our school (https://www.kcl.ac.uk/scms ) Our
-
interview for this position. For further information about the Department of Informatics at King's, please visit https://www.kcl.ac.uk/informatics About the role Key responsibilities include: Contributing
-
Engineering & Imaging Sciences (BMEIS) and the Royal Brompton Hospital’s Imaging Department in Chelsea. The School of BMEIS (https://www.kcl.ac.uk/bmeis ) is committed to improving the way we deliver healthcare
-
. Fellowships provide a competitive salary and up to £30,000 in research expenses for 18–24 months, enabling fellows to establish a distinctive research programme and prepare competitive applications
-
About us The Faculty of Natural, Mathematical & Engineering Sciences (NMES) comprises the Departments of Chemistry, Informatics, Mathematics, Physics and Engineering and is looking to recruit a
-
. This role will oversee a Phase 2/3 multi-arm, multi-stage (MAMS) trial evaluating the safety and efficacy of repurposed biosimilars and biologics in adults with epidermolysis bullosa (EB). https